Brown Advisory’s Medicines Co MDCO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-8,355
Closed -$228K 1318
2017
Q4
$228K Buy
8,355
+1,381
+20% +$42.5K ﹤0.01% 1128
2017
Q3
$258K Sell
6,974
-4,872
-41% -$180K ﹤0.01% 1044
2017
Q2
$451K Buy
11,846
+1,649
+16% +$73.4K ﹤0.01% 882
2017
Q1
$498K Buy
+10,197
New +$465K ﹤0.01% 816

Other funds holding MDCO

Brown Advisory's MDCO Position: Q1 2018 in Review

Brown Advisory sold out of Medicines Co (MDCO) in Q1 2018, closing a stake of 8,355 shares — an estimated $228K sold.

Brown Advisory first reported a position in MDCO in Q1 2017 and held it in 4 quarters. The position peaked at $498K in Q1 2017. 190 funds tracked by Wall St. Rank hold MDCO as of Q1 2018.

  • Brown Advisory reported no remaining Medicines Co position as of Q1 2018 after selling out during the quarter.
  • Brown Advisory sold 8,355 Medicines Co shares in Q1 2018, an estimated $228K.
  • Brown Advisory first reported a position in Medicines Co in Q1 2017 and held it in 4 quarters.
  • Brown Advisory's Medicines Co position peaked at $498K in Q1 2017.
  • 190 funds tracked by Wall St. Rank held Medicines Co as of Q1 2018.

Based on Brown Advisory's 13F filing for Q1 2018, filed 14 May 2018.